Growing community of inventors

San Francisco, CA, United States of America

Hassan Lemjabbar-Alaoui

Average Co-Inventor Count = 3.43

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Hassan Lemjabbar-AlaouiCsaba J Peto (6 patents)Hassan Lemjabbar-AlaouiDavid Jablons (6 patents)Hassan Lemjabbar-AlaouiTsze Tsang (3 patents)Hassan Lemjabbar-AlaouiDavid M Jablons (0 patent)Hassan Lemjabbar-AlaouiHassan Lemjabbar-Alaoui (6 patents)Csaba J PetoCsaba J Peto (26 patents)David JablonsDavid Jablons (24 patents)Tsze TsangTsze Tsang (33 patents)David M JablonsDavid M Jablons (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of California (6 from 15,458 patents)

2. Atlasmedx, Inc. (3 from 3 patents)


6 patents:

1. 12145925 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

2. 11708352 - Anti-cancer compounds

3. 11149025 - Anti-cancer compounds

4. 11072600 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

5. 10640493 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

6. 10562886 - Anti-cancer compounds

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…